TellBio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.2M
- Investors
-
5
TellBio General Information
Description
Operator of a biotechnology company intended for the treatment of cancer. The company revolutionizes the detection, monitoring, management, and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform, enabling doctors to detect and monitor the cancer progression of tumor cells.
Contact Information
Website
www.tellbio.comCorporate Office
- 19 Connector Road
- Suite 4
- Andover, MA 01810
- United States
Corporate Office
- 19 Connector Road
- Suite 4
- Andover, MA 01810
- United States
TellBio Timeline
TellBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 06-Jul-2024 | $2.2M | Completed | Product Development | ||
| 3. Early Stage VC (Series A2) | 29-Mar-2023 | Completed | Product Development | |||
| 2. Early Stage VC (Series A) | 16-Mar-2021 | $5M | $6.48M | Completed | Product Development | |
| 1. Seed Round | 05-Feb-2021 | $1.48M | $1.48M | Completed | Product Development |
TellBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A | ||||||||
| Seed | 750,000 | $0.001000 | $2 | $2 | 1x | $2 | 10.75% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
TellBio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TellBio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TellBio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARUP Laboratories | Corporation | Minority | ||
| Crocker Ventures | Venture Capital | Minority | ||
| Genetron Health | Corporation | Minority | ||
| National Foundation of Cancer Research | Not-For-Profit Venture Capital | Minority | ||
| AIM-HI | Accelerator/Incubator | Minority |
TellBio FAQs
-
When was TellBio founded?
TellBio was founded in 2019.
-
Where is TellBio headquartered?
TellBio is headquartered in Andover, MA.
-
What is the size of TellBio?
TellBio has 5 total employees.
-
What industry is TellBio in?
TellBio’s primary industry is Biotechnology.
-
Is TellBio a private or public company?
TellBio is a Private company.
-
What is TellBio’s current revenue?
The current revenue for TellBio is .
-
How much funding has TellBio raised over time?
TellBio has raised $11M.
-
Who are TellBio’s investors?
ARUP Laboratories, Crocker Ventures, Genetron Health, National Foundation of Cancer Research, and AIM-HI have invested in TellBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
